CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 32 enrolled
Drug / intervention
Methylphenidate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02051452
NCT02051452Phase 2Completed
CompareCT.gov

Reversal of General Anesthesia With Intravenous Methylphenidate

Massachusetts General Hospital·interventional·Posted Jan 31, 2014·Updated Aug 22, 2019

In Brief

A Phase 2 clinical trial evaluating Methylphenidate and Saline for Post Operative Cognitive Dysfunction and Emergence From Anesthesia. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure), a pancreatectomy, or a prostatectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Cognitive Dysfunction, Emergence From Anesthesia
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 31, 2014
Enrollment StartNov 1, 2014
Primary CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 12.4 years ago

Interventions

Methylphenidatedrug

Salineother